Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Frontiers in Neuroendocrinology|October 1, 2024
Effect of 5-alpha reductase inhibitors in animal models of Parkinson's diseaseMélanie Bourque, Marc Morissette, Amandine Isenbrandt, et al.
Synapse (New York, N.Y.)|November 10, 2007
Normalization of GABAA receptor specific binding in the substantia nigra reticulata and the prevention of L-dopa-induced dyskinesias in MPTP parkinsonian monkeysPershia Samadi, Marc Morissette, Fréderic Calon, et al.
Psychoneuroendocrinology|March 16, 2018
Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviorsLaura J Mosher, Sean C Godar, Marc Morissette, et al.
Neurobiology of Aging|March 14, 2007
mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeysPershia Samadi, Laurent Grégoire, Marc Morissette, et al.
NPJ Parkinson'S Disease|May 7, 2026
High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's diseaseCyntia Tremblay, Laura Pshevorskiy, Rosalie J Cottez, et al.
Plos One|March 10, 2016
Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP MiceEdith Miville-Godbout, Mélanie Bourque, Marc Morissette, et al.
Frontiers in Pharmacology|August 8, 2022
Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson's Disease ModelsAndrée-Anne Poirier, Mélissa Côté, Hend Jarras, et al.
Parkinsonism & Related Disorders|June 16, 2004
Relevance of the MPTP primate model in the study of dyskinesia priming mechanismsPierre J Blanchet, Frédéric Calon, Marc Morissette, et al.
Neurobiology of Aging|December 29, 2009
Metabotropic glutamate receptor type 5 in levodopa-induced motor complicationsBazoumana Ouattara, Laurent Grégoire, Marc Morissette, et al.
Pageof 8